British Land completes Life Science REIT acquisition

The acquisition of Life Science REIT by The British Land Company through a Scheme of Arrangement has become effective on 20 April.

Life Science REIT

Following the Court's sanction on 16 April 2026, and registration of the Court Order, British Land now owns the entire issued and to be issued share capital of Life Science REIT. Life Science REIT is expected to re-register as a private limited company soon.

Payment of the acquisition consideration to eligible Life Science REIT shareholders will be completed by 4 May 2026.

As previously announced, trading of Life Science REIT Shares on the Official List and Main Market was suspended.  at 7:30 a.m. today. The formal cancellation of Life Science REIT Shares from the Official List and their admission to trading on the Main Market is anticipated on 21 April 2026.

With the Scheme now effective, Claire Boyle, Sally Ann Forsyth, Richard Howell, Robert Naylor, and Michael Taylor have resigned from the Life Science REIT Board. Gavin Bergin, Michael Wiseman, Paul Case, and Rhiannon Owen have been appointed to the board.

Life Science REIT is a REIT investing in UK properties that are leased or intended to be leased to tenants operating in the life science sector.